418 related articles for article (PubMed ID: 11884458)
1. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
[TBL] [Abstract][Full Text] [Related]
2. Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects.
Storni T; Ruedl C; Schwarz K; Schwendener RA; Renner WA; Bachmann MF
J Immunol; 2004 Feb; 172(3):1777-85. PubMed ID: 14734761
[TBL] [Abstract][Full Text] [Related]
3. Loading of MHC class I and II presentation pathways by exogenous antigens: a quantitative in vivo comparison.
Storni T; Bachmann MF
J Immunol; 2004 May; 172(10):6129-35. PubMed ID: 15128799
[TBL] [Abstract][Full Text] [Related]
4. Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope.
Mazeike E; Gedvilaite A; Blohm U
Virus Res; 2012 Jan; 163(1):2-10. PubMed ID: 21864590
[TBL] [Abstract][Full Text] [Related]
5. Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes.
Shen X; Wong SB; Buck CB; Zhang J; Siliciano RF
J Immunol; 2002 Oct; 169(8):4222-9. PubMed ID: 12370352
[TBL] [Abstract][Full Text] [Related]
6. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.
Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H
J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072
[TBL] [Abstract][Full Text] [Related]
7. Immunoproteasomes down-regulate presentation of a subdominant T cell epitope from lymphocytic choriomeningitis virus.
Basler M; Youhnovski N; Van Den Broek M; Przybylski M; Groettrup M
J Immunol; 2004 Sep; 173(6):3925-34. PubMed ID: 15356141
[TBL] [Abstract][Full Text] [Related]
8. Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge.
Daftarian P; Ali S; Sharan R; Lacey SF; La Rosa C; Longmate J; Buck C; Siliciano RF; Diamond DJ
J Immunol; 2003 Oct; 171(8):4028-39. PubMed ID: 14530323
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity together with duration of antigen persistence regulate effector T cell induction.
Storni T; Ruedl C; Renner WA; Bachmann MF
J Immunol; 2003 Jul; 171(2):795-801. PubMed ID: 12847247
[TBL] [Abstract][Full Text] [Related]
10. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells efficiently induce protective antiviral immunity.
Ludewig B; Ehl S; Karrer U; Odermatt B; Hengartner H; Zinkernagel RM
J Virol; 1998 May; 72(5):3812-8. PubMed ID: 9557664
[TBL] [Abstract][Full Text] [Related]
12. 4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination.
Tan JT; Whitmire JK; Murali-Krishna K; Ahmed R; Altman JD; Mittler RS; Sette A; Pearson TC; Larsen CP
J Immunol; 2000 Mar; 164(5):2320-5. PubMed ID: 10679066
[TBL] [Abstract][Full Text] [Related]
13. CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide.
Miconnet I; Koenig S; Speiser D; Krieg A; Guillaume P; Cerottini JC; Romero P
J Immunol; 2002 Feb; 168(3):1212-8. PubMed ID: 11801657
[TBL] [Abstract][Full Text] [Related]
14. Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.
Velloso LM; Michaëlsson J; Ljunggren HG; Schneider G; Achour A
J Immunol; 2004 May; 172(9):5504-11. PubMed ID: 15100292
[TBL] [Abstract][Full Text] [Related]
15. Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
Bättig P; Saudan P; Storni T; Gallimore A; Bachmann MF
Microbes Infect; 2005 Apr; 7(4):729-37. PubMed ID: 15857805
[TBL] [Abstract][Full Text] [Related]
16. Antiviral protection after DNA vaccination is short lived and not enhanced by CpG DNA.
Oehen S; Junt T; López-Macías C; Kramps TA
Immunology; 2000 Feb; 99(2):163-9. PubMed ID: 10692032
[TBL] [Abstract][Full Text] [Related]
17. Protection against CTL escape and clinical disease in a murine model of virus persistence.
Kim TS; Perlman S
J Immunol; 2003 Aug; 171(4):2006-13. PubMed ID: 12902505
[TBL] [Abstract][Full Text] [Related]
18. Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant.
Crisci E; Almanza H; Mena I; Córdoba L; Gómez-Casado E; Castón JR; Fraile L; Bárcena J; Montoya M
Virology; 2009 May; 387(2):303-12. PubMed ID: 19327809
[TBL] [Abstract][Full Text] [Related]
19. Cross-presentation of virus-like particles by skin-derived CD8(-) dendritic cells: a dispensable role for TAP.
Ruedl C; Storni T; Lechner F; Bächi T; Bachmann MF
Eur J Immunol; 2002 Mar; 32(3):818-25. PubMed ID: 11870626
[TBL] [Abstract][Full Text] [Related]
20. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
